All News

With guidance from the American Association of Clinical Urologists, Inc., urologists have scored key grassroots victories in state legislatures across the country over the past year.

Infection-retardant coatings on penile prostheses, which have been shown to reduce primary implantation infection rates by more than half, appear to have minimal effect on bacterial growth based on culture data as found at the time of revision surgery.

Laparoscopic gastric band placement confers a lower lithogenic risk than the Roux-en-Y gastric bypass.

Managing a medical practice is a business proposition, and part of doing it right is being prepared for a new year.

Bevacizumab added to interferon-alpha as initial systemic therapy for metastatic renal cell carcinoma did not significantly improve overall survival compared to interferon alone, but did significantly increase progression-free survival.

In spite of the chaos of health care reform, urologists' mix of office, outpatient surgery, and hospital practice ensures that we will continue to do well.

A multicenter Japanese team has proposed a method for approaching infection prophylaxis with prostate biopsy patients.

The double whammy of declining reimbursement rates and rising overhead costs continues to plague practicing urologists in the United States.

Single nucleotide polymorphisms of the carbonic anhydrase 9 gene are found frequently in patients with metastatic renal cell carcinoma, and predict prognosis and response to immunotherapy.

Intermittent androgen ablation proved feasible for patients with metastatic prostate cancer, but did not improve survival or quality of life compared with continuous hormonal therapy.

It has become increasingly doubtful that even if Congress passes some form of health care reform this year or in early 2010, reform of the formula on which physician Medicare payments are calculated will most likely not be included, and that is bad news.

Measuring paired-like homeodomain transcription factor 2 methylation status may aid in predicting the risk of biochemical recurrence after radical prostatectomy.

The latest generation of mobile phones relagates the "talking" function to the background and offers users a wide array of activities once available only on desktop computers.

How will urologists be affected by reform measures aimed at bolstering the role of primary care physicians?

Information on new products from Accuray Inc., Covidien, Harvard Apparatus, EMG Productions, and KeyScan Inc.

Early results with tanezumab (RN624), an investigational monclonal antibody against nerve growth factor, show promise for chronic bladder pain in interstitial cystitis.

A vaccine against urinary tract infection is a step closer to reality in the United States.

Urologists offer opinions about the new guideline for baseline PSA testing.

Once again we face a Medicare payment update for the new year that raises a number of questions, the answers to which are not favorable to practicing urologists.

Michael O. Koch, MD, current chair of the Urology Residency Review Committee, discusses how the committee is dealing with important issues regarding the training of urologists.

This article focuses on the potentially dangerous urinary tract factors seen in spinal cord injury patients, with an emphasis on early and continuous treatment.

Three areas in urology currently rely upon the use of prostheses: artificial urinary sphincter for urinary incontinence, penile prosthesis for erectile dysfunction, and testicular prosthesis for congenital or acquired absent testis.

The FDA is warning consumers that Stiff Nights, a product marketed as a dietary supplement for sexual enhancement, contains an ingredient that can dangerously lower blood pressure and is illegal.

A new experimental procedure allows boys with cancer to have a tiny portion of their testis removed and frozen for potential future use, according to results of a recent study.

Some elevated PSA levels in men may be caused by a normally occurring hormone and are not necessarily a predictor of the need for a prostate biopsy, according to results of a recently published study.

Despite recent news reports disparaging prostate cancer testing, early detection of the disease remains in the best interest of the patient, according to an AUA statement clarifying its testing recommendations.

Unless Congress takes action, physicians paid under the Medicare fee schedule face another significant pay cut in 2010.

Roger Sur, MD, has been recruited by the University of California, San Diego Medical Center to launch a comprehensive kidney stone treatment center. The center is dedicated to the medical prevention, advanced surgical treatment, and research of kidney stone disease.